Polycystic Kidney Disease (PKD) Study

Posted on November 17, 2014

ABOUT THE STUDY

FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

 

WHO CAN JOIN THE STUDY?
YOU MAY BE ELIGIBLE FOR THIS STUDY IF YOU:
• Are 18 to 70 years of age
• Have been diagnosed with ADPKD

Other eligibility criteria will apply.

Please call our office at 614-487-2560 or email us at info@remdavis.com to schedule an appointment.

Facebook IconYouTube IconVisit Our LinkedIn Page